Latest News and Press Releases

MELBOURNE, Australia and INDIANAPOLIS, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today advises that Dr. Christian Behrenbruch,...

Hamilton, Bermuda, and Paris, France, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The RoyaLand Company Ltd. (“RoyaLand” or the “Company”) (OTCQB: RLNDF), a Bermuda holding company focused on creating an...

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis (“UC”) reaches 1,003 of 1,224...

Paris, 8 January, 2025 – 5:45 pm Pursuant to the liquidity agreement that Rubis has entered into with Exane BNP Paribas, the liquidity account presented the following balances as at the settlement...

PRESS RELEASEIvry-sur-Seine, France — January 8, 2025, 5.45 pm CEST THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IS NOT PERMITTED IN OR...

COMUNICATO STAMPAIvry-sur-Seine, Francia — 8 gennaio 2025, 5.45 pm CEST È VIETATA LA DIVULGAZIONE, LA PUBBLICAZIONE O LA DISTRIBUZIONE DEL PRESENTE COMUNICATO, IN TUTTO O IN PARTE, IN O VERSO GLI...

– Product Revenues, Net Expected in the Range of $735 Million to $750 Million – – Jornay PM® Net Revenue Expected to be in Excess of $135 Million – – Adjusted EBITDA* Expected in the Range of $435...

Totality of data observed with subcutaneous lonigutamab in Thyroid Eye Disease (TED) patients demonstrate potential for efficacy in line with standard of care and a more favorable safety profile ...

  Paris, 6 January 2025, 5:45 pm INFORMATION ON TOTAL NUMBER OF VOTING RIGHTS AND NUMBER OF SHARES PURSUANT TO ARTICLE L.233-8 II OF THE FRENCH COMMERCIAL CODE AND ARTICLE 223-16 OF THE GENERAL...

PRESS RELEASEIvry-sur-Seine, France — January 3, 2025, 2.00 pm CEST THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IS NOT PERMITTED IN OR...